Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing of general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
| Current Price | ₹1,306.60 |
|---|---|
| Market Cap | ₹901 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -64.6 |
| Return on Equity | -8.39% |
| Beta (1Y) | 0.72 |
| Dividend Yield | 0.08% |
1. Trading Of Pharma Products-18% 2. Contract Development And Manufacturing Operations-20.9% 3. Manufacturing Of Pharma Products-61.1%
Bharat Parenterals Ltd is trading at ₹1,306.60, with a market capitalisation of ₹901 Cr.
Bharat Parenterals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Bharat Parenterals Ltd has a P/E of -64.6 and a return on equity of -8.39%.